The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

Jul. 01, 2019
Applicant:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Inventors:

David J. Shapiro, Urbana, IL (US);

Paul J. Hergenrother, Champaign, IL (US);

Matthew W. Boudreau, Urbana, IL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 307/78 (2006.01); A61K 31/34 (2006.01); A61P 35/00 (2006.01); C07D 209/34 (2006.01); C07D 307/82 (2006.01); C07D 307/83 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 209/34 (2013.01); A61P 35/00 (2018.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 45/06 (2013.01);
Abstract

A set of small molecules ERα biomodulators that kill therapy-resistant ERα positive breast, ovarian, and endometrial cancer cells. These small molecules have increased therapeutic potential because of an increased ability to kill therapy-resistant breast cancer cells compared to BHPI and other conventional therapies (endocrine therapies, tamoxifen and fulvestrant/ICI). The new compounds do not only inhibit proliferation of the cancer cells but actually kills them, which prevents reactivation of tumors years later.


Find Patent Forward Citations

Loading…